[Adverse effects of combined use of acenocoumarol and acetylsalicylic acid after myocardial infarct and unstable angina].
The authors examined the bleeding complications in 75 patients who received acenocoumarol and acetylsalicylic acid combined therapy. The studied population suffered from either acute myocardial infarction or unstable angina. Among the 75 patients in two cases (2.7%) appeared serious bleeding and in another 25 cases (33.3%) mild bleeding complications. There were no fatal cases. Comparing these data with literary data, the authors stated that in the study group the proportion of serious complications didn't increase in comparison with patients who received either acenocoumarol, warfarin or acetylsalicylic acid but mild bleeding appeared more frequently. This finding suggests that in high risk patients the combined acenocoumarol-acetylsalicylic acid therapy can be considered under strict control.
Sámóczi
M
M
III. Belgyógyászati Osztály, Megyei Kórház-Rendelöintézet, Szombathely.
Farkas
A
A
Sipos
E
E
Tarján
J
J
D000074:Acenocoumarol / Q000009:adverse effects*; D000789:Angina, Unstable / Q000188:drug therapy*; D001241:Aspirin / Q000009:adverse effects*; D004357:Drug Synergism; D004359:Drug Therapy, Combination; D005260:Female; D006470:Hemorrhage / Q000139:chemically induced / Q000188:drug therapy; D006801:Humans; D008297:Male; D008875:Middle Aged; D009203:Myocardial Infarction / Q000188:drug therapy*; D011516:Prothrombin / Q000032:analysis; D014859:Warfarin / Q000009:adverse effects*
D014859:Warfarin; D011516:Prothrombin; D000074:Acenocoumarol; D001241:Aspirin
Acenocoumarol és acetylsalicylsav együttes alkalmazásának szövödményei szívinfarktus után és instabil anginában.